Sponsor Pipeline

Shandong New Time Pharmaceutical Co., LTD Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
14
Active Trials
5
Recruiting
6
Phase 3
5
Disease Areas
1
Changes, 30 Days
What Changed in the Last 30 Days
DetectedTrialChange
2026-08-09 NCT05408221
the Efficacy and Safety of Rulonilimab in Combination With Lenvatinib in Hepatocellular…
overall status: Recruiting → Unknown
New Trial Filings, Last 30 Days
First PostedTrialPhaseStatus
2026-08-12 NCT07761429 A Phase II/III Study of F520 Combined With Paclitaxel Plus Carboplatin in the Treatment… Phase 2/3 Recruiting
Active Trials by Phase
Phase 3
4
Phase 2/3
2
Phase 2
4
Phase 1
4
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT06819774 Phase III Clinical Study of Cetirizine Hydrochloride Injection in Treatment of Acute… Acute Urticaria Recruiting
NCT07579234 A Multicenter, Randomized, Open-label, Parallel-group, Controlled, Superiority Phase III… Relapsed or Refractory Multiple Myeloma (RRMM) Recruiting
NCT06863987 A Phase III Clinical Study of Valsartan Oral Solution for the Treatment of Hypertension… Essential Hypertension Enrolling by Invitation
NCT07046273 Phase III Clinical Study on the Efficacy and Safety of Semaglutide and Ozempic® in… Type 2 Diabetes (T2DM) Not Yet Recruiting
Phase 2/3
NCT07761429 A Phase II/III Study of F520 Combined With Paclitaxel Plus Carboplatin in the Treatment… Cancer of Unknown Primary Site Recruiting
NCT06755515 A Phase Ⅱ/Ⅲ Study of Rulonilimab Plus Chemotherapy± Bevacizumab for the First-Line… Cervical Cancer Enrolling by Invitation
Phase 2
NCT06782594 A Phase Ⅱ Study of Mosapride Citrate Injection in the Treatment of Postoperative… Postoperative Gastrointestinal Dysfunction Recruiting
NCT07312188 A Study of F182112 in the Treatment of Patients With Relapsed or Refractory Multiple… Relapsed or Refractory Multiple Myeloma Recruiting
NCT06722950 Phase II Clinical Study of AC591 in Preventing Oxaliplatin-Induced Peripheral Neuropathy Colorectal Adenoma Not Yet Recruiting
NCT06783257 Phase II Clinical Study of Vonorasan Fumarate Injection in the Treatment of Peptic Ulcer… Peptic Ulcer Bleeding Not Yet Recruiting
Phase 1
NCT06206915 Phase I Study of XZ120 in Malignant Tumors Advanced Malignancies Not Yet Recruiting
NCT06226363 Phase I Study of LNF1901 in Advanced Malignant Tumors Advanced Malignant Tumors Not Yet Recruiting
NCT06752447 A Phase I Study OfLNF2007 Monotherapy in Patients with Advanced Solid Tumors Advanced Solid Tumors (Phase 1) Not Yet Recruiting
NCT07661797 Phase I Clinical Study of LNF2105 in Patients With Advanced Solid Tumors Patients With Advanced Solid Tumors Not Yet Recruiting
Disease Areas
Get alerts when Shandong New Time Pharmaceutical Co., LTD's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free